author-photo

Nuri Karadurmuş

University of Health Sciences Antigua

19

Papers

22

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Thirty-day mortality rates after immunotherapy initiation.

2021 Immunotherapy
Show All
- Source
- Cite
- Save
Citations (0)
Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database.

2021 Future Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Secondary pneumothorax during immunotherapy in two patients with metastatic solid tumors; a new entity.

2021 Immunotherapy
Show All
- Source
- Cite
- Save
Citations (0)
"Swords and Shields" against COVID-19 for patients with cancer at "clean" and "pandemic" hospitals: are we ready for the second wave?

2021 Supportive Care in Cancer
Show All
- Source
- Cite
- Save
Citations (4)
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group

2021 Journal of Gastrointestinal Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Tolvaptan treatment in hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): effects on survival in patients with cancer

2020 International Urology and Nephrology
Show All
- Source
- Cite
- Save
Citations (1)
Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study):

2020 Journal of Oncology Pharmacy Practice
Show All
- Source
- Cite
- Save
Citations (1)
Treating relapsed and refractory metastatic germ cell tumours with high-dose chemotherapy with carboplatin and etoposide and autologous haematopoietic stem cell transplantation.

2020
Show All
- Source
- Cite
- Save
Citations (0)
Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer.

2020 Tumori
Show All
- Source
- Cite
- Save
Citations (1)
Assessment of the efficiency of Brentuximab Vedotin in patients with pulmonary Hodgkin Lymphoma by the mean of neutrophil to lymphocyte ratio

2017 Journal of Oncological Sciences
Show All
- Source
- Cite
- Save
Citations (0)